Advent follows EQT's lead with €200m div recap
Mediq, the Dutch pharmaceuticals firm owned by Advent, has launched a €200m dividend recapitalisation, holding an investor call on Wednesday. This follows German industrial services firm Bilfinger offering a €700m term loan at a bank meeting on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: